68th Annual Scientific Meeting In-person Evaluation

The American Headache Society’s Annual Scientific Meeting continues to be the premiere venue for disseminating the latest and most up-to-date research and scientific advances underlying the practice of Headache Medicine. AHS has dedicated over 60 years to leading and serving the headache community.

Course Instructions

AHS members should login using their membership credentials, and all others can create a new Visitor account or login as a Visitor using their existing visitor credentials. Once logged in, click "Take Course" to complete the meeting evaluation and claim CME.

Target Audience

The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

Learning Objectives

At the conclusion of the American Headache Society's 68th Annual Scientific Meeting, participants will report their intention to:

  • Evaluate potential new therapies and emerging clinical trial data in patients with migraine
  • Discuss adverse effects and side effects of treatments for primary headache disorders
  • Examine sensory hypersensitivities and nausea in primary headache disorders
  • Discuss the current data for biomarkers/biosignatures in post-traumatic headache and migraine
Course summary
Available credit: 
  • 21.00 AAFP
  • 21.00 ABPN Self-Assessment
  • 21.75 AMA PRA Category 1 Credit™
  • 21.75 Participation
Course opens: 
06/05/2026
Course expires: 
01/01/2027

Disclosure Information

The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

PURPOSE/OBJECTIVE

At the conclusion of the program, participants will share their intention to evaluate potential new therapies and emerging clinical trial data in patients with migraine, assess adverse effects and side effects of treatments for primary headache disorders, consider sensory hypersensitivities and nausea in primary headache disorders, and apply the current data for biomarkers/biosignatures in post-traumatic headache and migraine.

ACCREDITATION STATEMENT

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society® designates this Live activity for a maximum of 21.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP

The AAFP has reviewed 2025 Scottsdale Headache Symposium and deemed it acceptable for up to 21.00 Live AAFP Elective credit(s). Term of Approval is from 12/4/2025 to 12/7/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABPN

THE AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY HAS REVIEWED THE 2025 SCOTTSDALE HEADACHE SYMPOSIUM AND HAS APPROVED THIS ACTIVITY AS PART OF A COMPREHENSIVE SELF-ASSESSMENT (SA) CME ACTIVITY, WHICH IS MANDATED BY THE ABMS AS A NECESSARY COMPONENT OF CONTINUING CERTIFICATION.

This activity awards up to 21.00  Category 1 CME which are approved as Self-Assessment credits. The approval period is for December 4-7, 2025.

INSTRUCTIONS FOR CLAIMING CME:

  • Login/create a new visitor account (when creating an account, please be sure to use the email address you used during registration).
  • Complete the post-activity evaluation. 
  • For ABPN Self-Assessment Credit, complete the short ABPN Self-Assessment Quiz.
  • Enter the number of CME credits being claimed* per credit type.
  • Download your certificate. Certificates will only be issued for AMA PRA Category 1 Credit™(MDs/DOs) or Participation credit (all others).

*Please note: The maximum number of credits is calculated based on attending all live sessions. View CME hours per session on the program here.

FINANCIAL DISCLOSURES

The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERCIAL SUPPORT

The American Headache Society® received funding for this activity from the following organizations:

AbbVie Inc
Axsome Therapeutics, Inc.
John R. Graham Headache Center at Faulkner Hospital
Lundbeck LLC
Pfizer Inc

Available Credit

  • 21.00 AAFP
  • 21.00 ABPN Self-Assessment
  • 21.75 AMA PRA Category 1 Credit™
  • 21.75 Participation
Please login or register to take this course.